COVID-19 Test Mice in NIH-Funded Mutant Mice Catalog Humanized with Human Fetal Cells
The NIH-funded Mutant Mice Resource and Research Center established in 1999 is a national public repository of mutant mice providing test mice to the biomedical research community in the United States and abroad.
The MMRRC operates from four centers in the United States: the University of California-Davis, where it is part of the Mouse Biology Program, the University of North Carolina-Chapel Hill, the University of Missouri and the Jackson Laboratory in Maine.
The MMRRC has an online catalog where researchers may purchase test mice and offers several varieties of COVID-19 test mice models. In the first category, the ACE2 models, one strain, labeled B6J.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc, is of the greatest interest.
Screenshot of the catalog description from the MMRC website:
The description of the mutation:
Transgenic mice overexpressing human ACE2 under the control of the human forkhead box J1 (FOXJ1 – NCBI:2302) promoter, which is active in lung ciliated epithelial cells. RT-PCR analysis revealed expression in the lungs but also in other tissues (PCR - brain, liver, kidney, GI – PMID:26976607). The model also expresses mouse Ace2. Utility as a SARS-CoV-2 infection model has been confirmed (PMID:32516571) (Emphasis added.)
The two links in red go to the 2016 Menachery et al. study conducted by Ralph S. Baric and UNC researchers entitled, "SARS-like WIV1-CoV poised for human emergence."
The objective of that key NIH-funded study was to establish the following:
Focusing on the severe acute respiratory syndrome (SARS)-like viruses, the results indicate that the WIV1-coronavirus (CoV) cluster has the ability to directly infect and may undergo limited transmission in human populations.
As Dr. Kathleen Ruddy (internationally recognized breast cancer surgeon trained at Memorial Sloan-Kettering Cancer Center, founder of the Breast Health and Healing Foundation and and also affiliated with Harvard Medical School) explains in her video, "No Abortion, No Pandemic: How Fetal Tissue Was Used to Create the SARS CoV-2 Spike Protein," the mice in the Menachery et al. were humanized with fetal clone serum, a hormone synthesized from human fetal tissue.
Another ingredient used in the B6J.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc mutant mice model as listed in the screenshot above and also used in the Menachery et al. study, was the FOXj1 antibody.
The FOXj1/HFH4 is derived from human embryonic stem cells as described here in the Novus Biologicals online catalog:
Screenshot from the catalog:
In the Menachery et al study, the SARS-CoV2 pathogen made transmissible to humans by Ralph Baric and his collaborators at UNC and Wuhan with the use of mice humanized with human fetal tissue-derived fetal clone serum and the HFH4/FOXj1 antibody which was selected with the use of the HEK293 stem cell line.
It would appear that the mutant mice being offered in the MMRRC catalog were engineered using the same process as the humanized mice models used in the landmark Menachery et al. study and were humanized with human fetal tissue-derived ingredients.
Dr. Ruddy arrived at this devastating conclusion in her video:
“We’ve got fetal tissue rocking through the creation of the agent that was let loose on the world and has devastated the world. Brought us to our collective knees, created chaos, created collapse in our finances and our economies, and so on. You can’t do this kind of research without abortion. You don’t get humanized mice without humans, and you don’t get the human part without fetal tissue, and you don’t get fetal tissue unless you’re doing abortions.”
Fetal tissue rocked through the creation of the SARS-COV2 pathogen, and, as I have endeavored to document, it continues to rock through the creation of its antidotes and the engineering of its mice test models.